Adamed Technology

Overview

Adamed Technology is the corporate venture capital arm of Adamed Pharma, a leading Polish pharmaceutical company. Established in 2015, Adamed Technology specializes in investing in early-stage companies within the pharmaceutical and biotechnology sectors. The firm operates independently from Adamed Pharma's core pharmaceutical business, focusing on achieving returns on investment without seeking majority ownership or exclusive incorporation of startups' products into Adamed's portfolio. Adamed Technology is an evergreen fund, allowing for greater patience regarding the expected return period, and prefers trade sales over IPOs as an exit form. The firm invests exclusively in projects related to health and its protection, including areas such as biotechnology, healthcare, medtech, and digital health. Adamed Technology has invested in over 20 companies across various countries, including Poland, Austria, Belgium, Bulgaria, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Israel, Latvia, Lithuania, Netherlands, Norway, Portugal, Romania, Slovenia, Spain, Sweden, Switzerland, United Kingdom, and United States. Notable investments include Inuru, a Berlin-based company specializing in OLED technology for interactive labels, and One Biosciences, a French biotechnology firm focused on precision oncology. Adamed Technology's investment size ranges from €25,000 to over €5 million, supporting startups at various stages from pre-seed to late stage. The firm's approach combines financial investment with comprehensive support, including access to laboratory infrastructure, mentoring from experts in medicine, pharmaceutical sciences, biotechnology, medical chemistry, biology, and industrial property law, as well as assistance in market data, business model validation, and sales strategy development. This holistic support aims to accelerate the growth and commercialization of innovative solutions in the healthcare sector. Adamed Technology's involvement in acceleration programs further demonstrates its commitment to fostering innovation in the healthcare industry. The firm has partnered with organizations such as the Foundation for Technology Entrepreneurship (FPT) to support the development of innovative startups in Central and Eastern Europe. These programs aim to combine the potential of startups with the knowledge and resources of leading enterprises and the experience of Polish and international mentors. By participating in these initiatives, Adamed Technology not only provides financial backing but also contributes to the strategic guidance and mentorship necessary for startups to succeed in the competitive healthcare market. This collaborative approach underscores Adamed Technology's dedication to nurturing the next generation of healthcare innovators and ensuring the successful commercialization of groundbreaking medical technologies. Through its strategic investments and active participation in acceleration programs, Adamed Technology plays a pivotal role in advancing the healthcare sector by supporting the growth of innovative startups. The firm's focus on early-stage investments, combined with its comprehensive support system, enables startups to navigate the challenges of product development and commercialization effectively. By leveraging its extensive network and expertise, Adamed Technology continues to drive progress in the pharmaceutical and biotechnology industries, contributing to the development of solutions that address critical healthcare needs globally.

Investment Focus

• Projects related to health and its protection
• Innovative solutions in pharmaceutical and biotechnology sectors
• Startups at various stages from pre-seed to late stage

Portfolio Companies